Back to SYRE
UBS Group AG SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
16
Latest value
$30K
Q3 2026
Peak value
$69.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6.5M |
| Q3 2025 | $3K |
| Q4 2025 | $22.1M |
| Q4 2025 | $128K |
| Q4 2025 | $18K |
| Q1 2026 | $4K |
| Q1 2026 | $32.9M |
| Q1 2026 | $996K |
| Q2 2026 | $309K |
| Q2 2026 | $69.6M |
| Q2 2026 | $4.9M |
| Q2 2026 | $3K |
| Q3 2026 | $40K |
| Q3 2026 | $66.6M |
| Q3 2026 | $8.1M |
| Q3 2026 | $30K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30K | 341 | — | — |
| Q3 2026 | $8.1M | 90.7K | — | — |
| Q3 2026 | $66.6M | 748.5K | — | — |
| Q3 2026 | $40K | 453 | — | — |
| Q2 2026 | $3K | 31 | — | — |
| Q2 2026 | $4.9M | 55.7K | — | — |
| Q2 2026 | $69.6M | 783.9K | — | — |
| Q2 2026 | $309K | 3.5K | — | — |
| Q1 2026 | $996K | 19.8K | — | — |
| Q1 2026 | $32.9M | 651.4K | — | — |
| Q1 2026 | $4K | 87 | — | — |
| Q4 2025 | $18K | 543 | — | — |
| Q4 2025 | $128K | 3.9K | — | — |
| Q4 2025 | $22.1M | 676.1K | — | — |
| Q3 2025 | $3K | 176 | — | — |
| Q3 2025 | $6.5M | 385.4K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$348.1M
$336.7M
$318.8M